{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:00:50Z","timestamp":1785135650419,"version":"3.55.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2708184","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:19:17Z","timestamp":1785133157000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023\u201324 in six European countries: a VEBIS-EHR network study"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1627-4992","authenticated-orcid":false,"given":"Alexandre","family":"Blake","sequence":"first","affiliation":[{"name":"Epiconcept","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Humphreys","sequence":"additional","affiliation":[{"name":"Epiconcept","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Olson","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC)","place":["Solna, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Braeye","sequence":"additional","affiliation":[{"name":"Sciensano","place":["Elsene, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaak","family":"Van Evercooren","sequence":"additional","affiliation":[{"name":"Sciensano","place":["Elsene, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Holm","family":"Hansen","sequence":"additional","affiliation":[{"name":"Statens Serum Institut","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Rask","family":"Moustsen-Helms","sequence":"additional","affiliation":[{"name":"Statens Serum Institut","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-7117","authenticated-orcid":false,"given":"Massimo","family":"Fabiani","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mateo-Urdiales","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Castilla","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra \u2013 IdiSNA","place":["Pamplona, Spain"]},{"name":"CIBER on Epidemiology and Public Health","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Mart\u00ednez-Baz","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra \u2013 IdiSNA","place":["Pamplona, Spain"]},{"name":"CIBER on Epidemiology and Public Health","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausenda","family":"Machado","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge","place":["Lisboa, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Brito","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge","place":["Lisboa, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickard","family":"Ljung","sequence":"additional","affiliation":[{"name":"Swedish Medical Products Agency","place":["Uppsala, Sweden"]},{"name":"Institute of Environmental Medicine, Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicklas","family":"Pihlstr\u00f6m","sequence":"additional","affiliation":[{"name":"Swedish Medical Products Agency","place":["Uppsala, Sweden"]},{"name":"Institute of Environmental Medicine, Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Mansiaux","sequence":"additional","affiliation":[{"name":"Epiconcept","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Nicolay","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC)","place":["Solna, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Monge","sequence":"additional","affiliation":[{"name":"Institute of Health Carlos III","place":["Madrid, Spain"]},{"name":"CIBER on Infectious Diseases","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Nunes","sequence":"additional","affiliation":[{"name":"Epiconcept","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VEBIS-EHR working group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100996"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh2712"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-022-00683-z"},{"key":"e_1_3_7_5_1","unstructured":"WHO SAGE roadmap for prioritizing uses of COVID-19 vaccines: an approach to optimize the global impact of COVID-19 vaccines based on public health goals global and national equity and vaccine access and coverage scenarios [Internet]. [cited 2025 Jul 10]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2023.1"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002374"},{"key":"e_1_3_7_7_1","unstructured":"Vaccine monitoring platform (VMP) research agenda [Internet]. 2023 [cited 2025 Oct 6]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/vaccine-monitoring-platform-vmp-research-agenda"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100747"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1259"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.05.067"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03457-1"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7406a1"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106261"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7304a2"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.04.011"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.17402"},{"key":"e_1_3_7_17_1","unstructured":"erviss.org [Internet]. [cited 2025 Aug 27]. Available from: https:\/\/erviss.org\/"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q1496"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12091072"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00806-5"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12010016"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107307"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2428800"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13292"},{"key":"e_1_3_7_25_1","unstructured":"Protocol for COVID-19 vaccine effectiveness multi-country study (VEBIS) using health data registries - version 3.0. Internet. 2025 [cited 2025 Mar 17]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/protocol-covid-19-vaccine-effectiveness-multi-country-study-vebis-using-health"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.6028\/jres.087.022"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52668-w"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwad191"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2035222"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13360"},{"key":"e_1_3_7_32_1","unstructured":"SAFETY-VAC: Phenotype proposal and rates of immunocompromised populations in real-world data sources. HMA-EMA catalogues of real-world data sources and studies [Internet]. [cited 2025 Jul 7]. Available from: https:\/\/catalogues.ema.europa.eu\/node\/4189\/resources"},{"key":"#cr-split#-e_1_3_7_33_1.1","unstructured":"European Centre for Disease Prevention and Control. COVID-19 vaccination coverage in the EU\/EEA during the 2023-24 season campaigns 1 September 2023 to 31 July 2024. [Internet]. LU: Publications Office"},{"key":"#cr-split#-e_1_3_7_33_1.2","unstructured":"2024 [cited 2025 Mar 4]. Available from: https:\/\/data.europa.eu\/doi\/10.2900\/1677733"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106432"},{"key":"e_1_3_7_35_1","unstructured":"Administrator VD. Joint statement on the protection of immunocompromised patients during the COVID-19 pandemic [Internet]. ECPC - European cancer patient coalition. 2022 [cited 2025 Feb 4]. Available from: https:\/\/ecpc.org\/joint-statement-on-the-protection-of-immunocompromised-patients\/"},{"key":"e_1_3_7_36_1","unstructured":"Homepage | ECIS - European cancer information system [Internet]. [cited 2025 Mar 6]. Available from: https:\/\/ecis.jrc.ec.europa.eu\/"},{"key":"e_1_3_7_37_1","unstructured":"Global burden of Disease collaborative network. Global burden of Disease study 2021 (GBD 2021) results. Internet. Seattle (USA): Institute for Health Metrics and Evaluation (IHME; 2022; Available from: https:\/\/vizhub.healthdata.org\/gbd-results\/"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb2506929"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2023.11.005"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2708184","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14760584.2026.2708184","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2708184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:19:20Z","timestamp":1785133160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2708184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2708184"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2708184","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2708184"}}